We are live on ! Find out more
VVM

Versant Venture Management Portfolio holdings

AUM $163M
1-Year Est. Return 240.43%
This Fund
S&P 500
This Quarter Est. Return
-22.8%
1 Year Est. Return
+240.43%
3 Year Est. Return
+409.28%
5 Year Est. Return
+142.09%
10 Year Est. Return
+4,071.98%
AUM
$202M
AUM Growth
-$92M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRSP icon
1
CRISPR Therapeutics
CRSP
$5.12B
$103M 51.04%
3,608,874
– –
VCYT icon
2
Veracyte
VCYT
$3.29B
$45.5M 22.52%
3,616,221
– –
BOLD
3
DELISTED
Audentes Therapeutics, Inc
BOLD
$25.7M 12.71%
1,204,615
– –
OCUL icon
4
Ocular Therapeutix
OCUL
$2.3B
$8.82M 4.36%
2,215,384
– –
CBAY
5
DELISTED
Cymabay Therapeutics
CBAY
$8.54M 4.23%
1,084,696
– –
VANI icon
6
Vivani Medical
VANI
$115M
$3.98M 1.97%
187,207
– –
IMDZ
7
DELISTED
Immune Design Corp.
IMDZ
$2.87M 1.42%
2,208,210
– –
CLVS
8
DELISTED
Clovis Oncology, Inc.
CLVS
$1.83M 0.91%
101,855
– –
AKAO
9
DELISTED
Achaogen Inc
AKAO
$1.58M 0.78%
1,281,152
– –
OPGN
10
DELISTED
OpGen, Inc
OPGN
$133K 0.07%
26
– –

Similar funds

TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
GF
Gimbal Financial Carmel, Indiana $163M AUM
ACM
Arrington Capital Management Miami, Florida $163M AUM
KFS
Krane Financial Solutions Calabasas, California $162M AUM
VB
Value Base Tel Aviv, Israel $162M AUM 2.31% 1-Year Est. Return
RWA
Reicon Wealth Advisors Atlanta, Georgia $162M AUM
CCM
Candelo Capital Management New York $162M AUM 112.87% 1-Year Est. Return
GCM
Generation Capital Management Pittsford, New York $163M AUM 42.22% 1-Year Est. Return

Versant Venture Management's Q4 2018 Portfolio in Review

As of Q4 2018, Versant Venture Management held 10 positions worth $202M, down 31% from $294M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 0%. Versant Venture Management opened no new positions and made no exits, leaving the 10-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Versant Venture Management's ten largest holdings make up 100% of its $202M portfolio in Q4 2018.
  • Versant Venture Management opened 0 new positions and closed 0 in Q4 2018.
  • Versant Venture Management's portfolio value fell 31% quarter-over-quarter to $202M.

Based on Versant Venture Management's 13F filing for Q4 2018, filed 22 Jan 2019.